Loading
Fitlife Brands, Inc. Stock: price and insider trades · United States
1 insider bought €8,851 of shares over the last 90 days, the latest by Pappas Shannon K., filed 21 Aug 2026.
Fitlife Brands, Inc.: what insiders have been doing
Fitlife Brands, Inc. is a Food & Agriculture company. Its directors and officers file their transactions with SEC (Form 4). 4 insiders have disclosed 4 filings since 22 October 2025.
The flow runs one way only: 4 insiders bought (4 purchases totalling €62k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 4 senior executives. Biggest ticket of the year: €26k, bought by Dawson Grant Robert and made public on 14 April 2026 (0.029% of market cap).
In the case of 2 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The clock since the last published purchase (21 August 2026) now reads 64 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade.
With 4 filings in twelve months, the company is quieter than the median of 24 filings across the 3,171 companies we follow on the same exchange. Looking back to 2016, when coverage begins, insiders filed 60 purchases and 6 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 81.5 m USD and net income at 6.3 m USD.
In the same market, recent insider purchases at Xenon Pharmaceuticals Inc. and Applied Digital Corp. also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
122
Thresholds
n/a
Buy Volume
€2M
60 ops. · all time
Sell Volume
€777,238
6 ops. · all time
Who traded when
BuySaleMatthew Lingenbrink3 buys
Todd Ordal2 buys
Grant Robert Dawson1 buy
Seth Yakatan1 buy
Shannon K. Pappas1 buy
Since the insiders bought
- -17.6%Entry US$10.00 · Close 21 Oct 2026 US$8.24
- +18.0%Entry US$9.32 · Close at T+90 US$11.00
- +19.5%Entry US$9.30 · Close at T+90 US$11.11
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,415 of 26,280 companies
62.5
score / 100
Value69
Quality56
FCF yld9.7%
Earn yld8.3%
EV/EBITDA11.6x
ROE14%
Gross mgn39%
Net mgn7.8%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$8.13
Analyst consensus
2 analysts1.00/5
US$17.00Target US$17.50(+115%)US$18.00
Income statement
RevenueUS$81.5M
Gross profitUS$31.5M39% margin
EBITDAUS$10.5M13% margin
Net incomeUS$6.3M6.2% margin
Valuation
PER (trailing)13.1x
PER (forward)6.3x
P/Book1.6x
Beta0.06
Balance sheet & cash
Market capUS$76.3M
Total debtUS$45.2M
Free Cash FlowUS$7.4M
Debt / Equity81%
Profitability & ownership
ROE14.1%
ROA9.9%
% insiders15.2%
% institutions56.3%
Last declaration on 21 August 2026
Declarations122 total
1,000 shares@ US$10.250.012% mcap100.0% of flowCommon StockSEC:0002067544-26-000002:0
Canonical exit: 17 Nov 2026 (T+90)
164 shares@ US$15.3601100.0% of flowCommon StockSEC:0001318798-26-000004:0
Canonical exit: 15 Apr 2026 (T+90)
3,000 shares@ US$9.980.029% mcap50.4% of flowCommon StockSEC:0001465378-26-000002:0
Canonical exit: 9 Jul 2026 (T+90)
3,000 shares@ US$9.760.028% mcap28.2% of flowCommon StockSEC:0002033776-26-000002:0
Canonical exit: 9 Jul 2026 (T+90)
300 shares@ US$12.0742.0% of flowCommon StockSEC:0001415889-25-010737:0
Canonical exit: 14 Jul 2025 (T+90)
3,000 shares@ US$12.1736.3% of flowCommon StockSEC:0001415889-25-010736:0
Canonical exit: 13 Jul 2025 (T+90)
2,800 shares@ US$12.174835.5% of flowCommon StockSEC:0001415889-25-009491:0
Canonical exit: 29 Jun 2025 (T+90)
144,000 shares@ US$2.6263.7% of flowCommon StockSEC:0001415889-25-009489:0
2,144 shares@ US$12.681149.6% of flowCommon StockSEC:0001415889-25-009204:0
150 shares@ US$30.3758.0% of flowCommon StockSEC:0001415889-25-001579:0
Canonical exit: 15 Apr 2025 (T+90)
6,200 shares@ US$0.700.8% of flowCommon StockSEC:0001415889-25-000100:0
4,000 shares@ US$32.8030.3% of flowCommon StockSEC:0001415889-24-015443:1
2,544 shares@ US$31.5018.5% of flowCommon StockSEC:0001415889-24-015443:2
4,000 shares@ US$31.0056.2% of flowCommon StockSEC:0001415889-24-015443:0
8,600 shares@ US$0.701.0% of flowCommon StockSEC:0001415889-24-000038:0
4,000 shares@ US$24.5043.8% of flowCommon StockSEC:0001415889-23-016730:0
143,480 shares@ US$1.1528.7% of flowCommon StockSEC:0001415889-23-014014:0
1,000 shares@ US$17.00100.0% of flowCommon StockSEC:0001415889-23-008298:0
Canonical exit: 16 Aug 2023 (T+90)
52,000 shares@ US$0.705.9% of flowCommon StockSEC:0001415889-21-006305:0
9,023 shares@ US$28.5089.9% of flowCommon StockSEC:0001415889-21-002035:0
40,000 shares0Common StockSEC:0001415889-21-000616:0
174 shares@ US$21.601.3% of flowCommon StockSEC:0001415889-21-000003:0
14,431 shares@ US$13.5023.3% of flowCommon StockSEC:0001415889-20-002482:0
Canonical exit: 14 Jan 2021 (T+90)
14,431 shares@ US$13.50100.0% of flowCommon StockSEC:0001415889-20-002484:0
255 shares@ US$14.7515.4% of flowCommon StockSEC:0001415889-20-002360:0
25 of 122 declarations
About Fitlife Brands, Inc.
FitLife Brands, Inc. (ticker: FTLF) is a U.S.-based company listed on the NASDAQ Capital Market and headquartered in Omaha, Nebraska, United States. For French-speaking investors, the company sits in the consumer health, sports nutrition, and wellness space, with a business model built around branded nutritional supplements and proprietary formulations rather than a single flagship product. The company describes itself as a provider of innovative and proprietary nutritional and fitness enhancement products for health-conscious consumers, and it emphasizes brand-led growth across multiple consumer niches. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/ftlf20251231_10k.htm?utm_source=openai))
FitLife Brands has developed a portfolio spanning several subcategories of the supplement market, including sports nutrition, performance, weight management, digestion, and broader wellness. Its SEC filings identify brand families such as NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All Natural Advice, Maritime Naturals, MusclePharm, and Irwin Naturals. This diversified brand set gives the company exposure to several consumer segments and supports multiple routes to market, particularly online sales, wholesale distribution, and select retail partners. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/ftlf20251231_10k.htm?utm_source=openai))
Read moreShow less
From a competitive standpoint, FitLife operates in a fragmented and highly promotional industry where success depends on brand recognition, formula differentiation, digital marketing effectiveness, and distribution access. Its focus on proprietary products and health-oriented branding can support pricing power and customer loyalty, but the business also faces the usual pressures of the category: intense competition, shifting consumer preferences, and sensitivity to marketing spend and retailer relationships. Recent SEC disclosures show that online revenue remains important, while wholesale channels also contribute meaningfully to the mix. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/ftlf20251231_10k.htm?utm_source=openai))
A major recent development was the closing, on August 8, 2025, of the acquisition of substantially all assets of Irwin Naturals and related affiliates, following approval by the U.S. Bankruptcy Court for the Central District of California. This transaction expanded the company’s brand portfolio and changed the revenue mix, with management noting that the addition of Irwin reduced the proportion of sales coming from online channels because Irwin contributed little online revenue at the time of acquisition. FitLife’s 2025 annual report also states that revenue growth for the year was primarily driven by this acquisition. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774925025813/ex_850619.htm?utm_source=openai))
For investors, the key questions are execution and integration: how effectively FitLife can absorb acquired brands, stabilize channel performance, and improve profitability while managing a relatively leveraged capital structure and a competitive supplement market. The company’s public disclosures, including SEC Form 4 insider transaction filings, provide additional transparency for monitoring management activity and corporate momentum. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000203377626000002/xslF345X06/form4-04142026_040403.xml?utm_source=openai))
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
